Science, institutions, and markets: developments in the Indian biotechnology sector
Bagchi-Sen, S. and Lawton-Smith, Helen (2008) Science, institutions, and markets: developments in the Indian biotechnology sector. Regional Studies 42 (7), pp. 961-975. ISSN 0034-3404.
To be competitive Indian pharmaceutical and biotechnology companies pursue both imitative and innovation-based strategies. Some undertake contractual clinical research from multinationals now that product patents have replaced process patenting. The barriers for innovation are the lack of funds and regulations. Government funding bodies have to reconcile the goals: science for society versus science for profit. The regulatory process (e.g. time taken for drug approvals) is in need of change. In recent years the industry has become more regionalized - states are proactive in promoting bioscience complexes through parks and institutes (e.g. Bangalore and Hyderabad). This has implications for clustered economic development.
|School:||Birkbeck Schools and Departments > School of Business, Economics & Informatics > Management|
|Research Centre:||Innovation Management Research, Birkbeck Centre for|
|Date Deposited:||27 Jan 2011 16:54|
|Last Modified:||06 Dec 2016 10:06|
Additional statistics are available via IRStats2.